Cytos Biotechnology (Monoclonal Antibody Technology Business) is Other Healthcare Technology Systems in Switzerland that focus on related researches business. They cover business area such as Owner, an operator, technology platform, service, platform technology, antibody, relate research.
Other Healthcare Technology Systems
-
Related Researches
-
Wagistrasse 25
Postfach
8952 Schlieren
Switzerland
Private
Owneran operatortechnology platformserviceplatform technologyantibodyrelate research
* We use standard office opening hours in near Cytos Biotechnology (Monoclonal Antibody Technology Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cytos Biotechnology (Monoclonal Antibody Technology Business) is Other Healthcare Technology Systems business from Switzerland that founded in - ( years old in ), Cytos Biotechnology (Monoclonal Antibody Technology Business) business is focusing on Related Researches.
Cytos Biotechnology (Monoclonal Antibody Technology Business) headquarter office and corporate office address is located in Wagistrasse 25 Postfach 8952 Schlieren Switzerland.
Cytos Biotechnology (Monoclonal Antibody Technology Business) was founded in Switzerland.
In , Cytos Biotechnology (Monoclonal Antibody Technology Business) is currently focus on related researches sector.
Above is snippet of Google Trends for "related researches" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cytos Biotechnology (Monoclonal Antibody Technology Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
